Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association

MT Donofrio, AJ Moon-Grady, LK Hornberger… - Circulation, 2014 - Am Heart Assoc
Background—The goal of this statement is to review available literature and to put forth a
scientific statement on the current practice of fetal cardiac medicine, including the diagnosis …

The clinical spectrum of autoimmune congenital heart block

P Brito-Zerón, PM Izmirly, M Ramos-Casals… - Nature Reviews …, 2015 - nature.com
Autoimmune congenital heart block (CHB) is an immune-mediated acquired disease that is
associated with the placental transference of maternal antibodies specific for Ro and La …

Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA/Ro-positive mothers

P Izmirly, M Kim, DM Friedman… - Journal of the American …, 2020 - jacc.org
Background Experimental and clinical evidence support the role of macrophage Toll-like
receptor signaling in maternal anti-SSA/Ro–mediated congenital heart block (CHB) …

[HTML][HTML] Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus

J Hartl, L Serpas, Y Wang, A Rashidfarrokhi… - Journal of Experimental …, 2021 - rupress.org
Disclosures: P. Izmirly reported personal fees from GlaxoSmithKline outside the submitted
work. JP Buyon reported personal fees from Bristol-Myers Squibb LN advisory board …

Autoimmune diseases

A Davidson, B Diamond - New England Journal of Medicine, 2001 - Mass Medical Soc
Autoimmune diseases, with the exception of rheumatoid arthritis and autoimmune thyroiditis,
are individually rare, but together they affect approximately 5 percent of the population in …

Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody–associated cardiac manifestations of neonatal lupus

PM Izmirly, N Costedoat-Chalumeau, CN Pisoni… - Circulation, 2012 - Am Heart Assoc
Background—A recent case-control study suggested a benefit of hydroxychloroquine (HCQ)
in lowering the risk of cardiac manifestations of neonatal lupus (cardiac-NL) in pregnancies …

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical …

GK Bertsias, JPA Ioannidis, J Boletis… - Annals of the …, 2008 - ard.bmj.com
Objective: Systemic lupus erythematosus (SLE) is a complex disease with variable
presentations, course and prognosis. We sought to develop evidence-based …

Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways

DW Benson, GM Silberbach… - The Journal of …, 1999 - Am Soc Clin Investig
Heterozygous mutations in NKX2. 5, a homeobox transcription factor, were reported to
cause secundum atrial septal defects and result in atrioventricular (AV) conduction block …

Autoantibodies in Sjögren's syndrome

A Fayyaz, BT Kurien… - Rheumatic Disease …, 2016 - rheumatic.theclinics.com
Sjogren's syndrome is characterized by the presence of a plethora of autoantibodies (Table
1). We herein review major recent development in autoantibodies associated with Sjogren …

Risk of congenital complete heart block in newborns of mothers with anti‐Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 …

A Brucato, M Frassi, F Franceschini… - Arthritis & …, 2001 - Wiley Online Library
Objective. To assess the true prevalence of con-genital complete heart block (CCHB) in
infants of anti-Ro/SSA–positive women known to have connective tissue disease (CTD) and …